{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:25:13Z","timestamp":1772166313130,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T00:00:00Z","timestamp":1708473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T00:00:00Z","timestamp":1708473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>One of the most relevant challenges for healthcare providers during the COVID\u2013 19 pandemic has been assuring the continuity of care to patients with complex health needs such as people living with rare diseases (RDs). The COVID\u201319 pandemic accelerated the healthcare sector\u2019s digital transformation agenda. The delivery of telemedicine services instead of many face-to-face procedures has been expanded and, many healthcare services not directly related to COVID-19 treatments shifted online remotely. Many hospitals, specialist centres, patients and families started to use telemedicine because they were forced to. This trend could directly represent a good practice on how care services could be organized and continuity of care could be ensured for patients. If done properly, it could boast improved patient outcomes and become a post COVID-19 major shift in the care paradigm. There is a fragmented stakeholders spectrum, as many questions arise on: how is e-health interacting with \u2018traditional\u2019 healthcare providers; about the role of the European Reference Networks (ERNs); if remote care can retain a human touch and stay patient centric. The manuscript is one of the results of the European Brain Council (EBC) Value of Treatment research project on rare brain disorders focusing on progressive ataxias, dystonia and phenylketonuria with the support of Academic Partners and in collaboration with European Reference Networks (ERNs) experts, applying empirical evidence from different European countries. The main purpose of this work is to investigate the impact of the COVID-19 pandemic on the continuity of care for ataxias, dystonia and phenylketonuria (PKU) in Europe. The analysis carried out makes it possible to highlight the critical points encountered and to learn from the best experiences. Here, we propose a scoping review that investigates this topic, focusing on continuity of care and novel methods (e.g., digital approaches) used to reduce the care disruption. This scoping review was designed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for scoping reviews (PRISMA-ScR) standards. This work showed that the implementation of telemedicine services was the main measure that healthcare providers (HCPs) put in place and adopted for mitigating the effects of disruption or discontinuity of the healthcare services of people with rare neurological diseases and with neurometabolic disorders in Europe.<\/jats:p>","DOI":"10.1186\/s13023-023-03005-9","type":"journal-article","created":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T07:03:23Z","timestamp":1708499003000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The COVID-19 pandemic impact on continuity of care provision on rare brain diseases and on ataxias, dystonia and PKU. A scoping review"],"prefix":"10.1186","volume":"19","author":[{"given":"Sara","family":"Cannizzo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinciane","family":"Quoidbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Giunti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Oertel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Pastores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maja","family":"Relja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1877-5459","authenticated-orcid":false,"given":"Giuseppe","family":"Turchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,21]]},"reference":[{"key":"3005_CR1","unstructured":"WHO. Coronavirus Disease (COVID-19) Dashboard. Available online:(latest access on 2 January 2024).https:\/\/covid19.who.int\/"},{"key":"3005_CR2","doi-asserted-by":"publisher","DOI":"10.1787\/b0118fae-en","volume-title":"Health at a glance 2021: OECD indicators","author":"M Mueller","year":"2021","unstructured":"Mueller M, et al. The health impact of COVID\u201319. Health at a glance 2021: OECD indicators. Paris: OECD Publishing; 2021. https:\/\/doi.org\/10.1787\/b0118fae-en."},{"issue":"3","key":"3005_CR3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41584-020-00565-z","volume":"17","author":"R Talarico","year":"2021","unstructured":"Talarico R, et al. The impact of COVID-19 on rare and complex connective tissue Diseases: the experience of ERN ReCONNET. Nat Rev Rheumatol. 2021;17(3):177\u201384. https:\/\/doi.org\/10.1038\/s41584-020-00565-z. Epub 2021 Jan 6. PMID: 33408338; PMCID: PMC7786339.","journal-title":"Nat Rev Rheumatol"},{"key":"3005_CR4","doi-asserted-by":"publisher","first-page":"8694","DOI":"10.3390\/ijerph17228694","volume":"17","author":"R Talarico","year":"2020","unstructured":"Talarico R, Marinello D, Cannizzo S, Gaglioti A, Ticciati S, Carta C, Kodra Y, Azadegan M, Taruscio D, Mosca M, Turchetti G. Shaping the future of Rare Diseases after a Global Health emergency: organisational points to consider. Int J Environ Res Public Health. 2020;17:8694. https:\/\/doi.org\/10.3390\/ijerph17228694.","journal-title":"Int J Environ Res Public Health"},{"key":"3005_CR5","doi-asserted-by":"crossref","unstructured":"Mazzoleni S, Turchetti G, Ambrosino N. The COVID-19 Outbreak: From Black Swan To Global Challenges and Opportunities. Pulmonology 2020, 26, 117\u2013118.","DOI":"10.1016\/j.pulmoe.2020.03.002"},{"key":"3005_CR6","doi-asserted-by":"publisher","DOI":"10.1787\/ac8b0a27-en","volume-title":"The COVID-19 pandemic and the future of Telemedicine, OECD Health Policy studies","author":"OECD","year":"2023","unstructured":"OECD. The COVID-19 pandemic and the future of Telemedicine, OECD Health Policy studies. Paris: OECD Publishing; 2023. https:\/\/doi.org\/10.1787\/ac8b0a27-en."},{"key":"3005_CR7","unstructured":"https:\/\/www.orpha.net\/consor4.01\/www\/cgi-bin\/Disease_Classif.php?lng=EN&data_id=181&PatId=14938&search=Disease_Classif_Simple&new=1"},{"key":"3005_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13023-019-1013-9","volume":"14","author":"R de Silva","year":"2019","unstructured":"de Silva R, Greenfield J, Cook A, et al. Guidelines on the diagnosis and management of the Progressive ataxias. Orphanet J Rare Dis. 2019;14:51. https:\/\/doi.org\/10.1186\/s13023-019-1013-9.","journal-title":"Orphanet J Rare Dis"},{"key":"3005_CR9","unstructured":"https:\/\/www.orpha.net\/consor4.01\/www\/cgi-bin\/Disease_Classif.php?lng=EN&data_id=181&PatId=10502&search=Disease_Classif_Simple&new=1"},{"key":"3005_CR10","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s00415-022-11412-4","volume":"270","author":"LM Centen","year":"2023","unstructured":"Centen LM, Pinter D, van Egmond ME, et al. Dystonia management across Europe within ERN-RND: current state and future challenges. J Neurol. 2023;270:797\u2013809. https:\/\/doi.org\/10.1007\/s00415-022-11412-4.","journal-title":"J Neurol"},{"key":"3005_CR11","doi-asserted-by":"publisher","unstructured":"Peters MDJ, Godfrey C, McInerney P, Munn Z, Tricco AC, Khalil H. Chapter 11: Scoping Reviews (2020 version). In: Aromataris E, Munn Z, editors. JBI Manual for Evidence Synthesis, JBI, 2020. Available from https:\/\/synthesismanual.jbi.global. https:\/\/doi.org\/10.46658\/JBIMES-20-12.","DOI":"10.46658\/JBIMES-20-12"},{"issue":"7","key":"3005_CR12","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D, Moher D, Peters MDJ, Horsley T, Weeks L, Hempel S, Akl EA, Chang C, McGowan J, Stewart L, Hartling L, Aldcroft A, Wilson MG, Garritty C, Lewin S, Godfrey CM, Macdonald MT, Langlois EV, Soares-Weiser K, Moriarty J, Clifford T, Tun\u00e7alp \u00d6, Straus SE. Checklist and Explanation. Ann Intern Med. 2018;169(7):467\u201373. https:\/\/doi.org\/10.7326\/M18-0850. Epub 2018 Sep 4. PMID: 30178033. PRISMA Extension for Scoping Reviews (PRISMA-ScR).","journal-title":"Ann Intern Med"},{"key":"3005_CR13","doi-asserted-by":"publisher","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71. For more information, visit: http:\/\/www.prisma-statement.org\/.","DOI":"10.1136\/bmj.n71"},{"key":"3005_CR14","doi-asserted-by":"publisher","unstructured":"Cannizzo S, Quoidbach V, Giunti P, Oertel W, Pastores G, Relja M, Turchetti G. The COVID-19 pandemic impact on continuity of care provision on rare brain Diseases and on Ataxia, Dystonia and PKU. A scoping review protocol. medRxiv. https:\/\/doi.org\/10.1101\/2022.07.26.22277799.","DOI":"10.1101\/2022.07.26.22277799"},{"issue":"11","key":"3005_CR15","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.3390\/healthcare9111407","volume":"9","author":"V Rovelli","year":"2021","unstructured":"Rovelli V, Zuvadelli J, Paci S, Ercoli V, Re Dionigi A, Selmi R, Salvatici E, Cefalo G, Banderali G. Telehealth and COVID-19: empowering standards of Management for patients affected by Phenylketonuria and Hyperphenylalaninemia. Healthc (Basel). 2021;9(11):1407. https:\/\/doi.org\/10.3390\/healthcare9111407. PMID: 34828453; PMCID: PMC8622759.","journal-title":"Healthc (Basel)"},{"issue":"2","key":"3005_CR16","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3390\/children9020131","volume":"9","author":"D Walkowiak","year":"2022","unstructured":"Walkowiak D, Miko\u0142u\u0107 B, Mozrzymas R, Ka\u0142u\u017cny \u0141, Didycz B, Koryci\u0144ska-Chaaban D, Patalan M, Jag\u0142owska J, Chrobot A, Staszewski R, Walkowiak J. Phenylketonuria patients\u2019 and their caregivers\u2019 perception of the pandemic lockdown: the results of a National Online Survey. Child (Basel). 2022;9(2):131. https:\/\/doi.org\/10.3390\/children9020131. PMID: 35204852; PMCID: PMC8869859.","journal-title":"Child (Basel)"},{"issue":"21","key":"3005_CR17","doi-asserted-by":"publisher","first-page":"4862","DOI":"10.3390\/jcm10214862","volume":"10","author":"E Tob\u00f3r-\u015awi\u0119tek","year":"2021","unstructured":"Tob\u00f3r-\u015awi\u0119tek E, Sykut-Cegielska J, Bik-Multanowski M, Walczak M, Rokicki D, Ka\u0142u\u017cny \u0141, Wierzba J, Pac M, Jahnz-R\u00f3\u017cyk K, Wi\u0119sik-Szewczyk E, Kie\u0107-Wilk B. COVID-19 pandemic and patients with Rare inherited metabolic disorders and Rare Autoinflammatory diseases-Organizational challenges from the point of View of Healthcare Providers. J Clin Med. 2021;10(21):4862. https:\/\/doi.org\/10.3390\/jcm10214862. PMID: 34768381; PMCID: PMC8584872.","journal-title":"J Clin Med"},{"issue":"4","key":"3005_CR18","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1007\/s12311-020-01139-1","volume":"19","author":"M Manto","year":"2020","unstructured":"Manto M, Dupre N, Hadjivassiliou M, Louis ED, Mitoma H, Molinari M, Shaikh AG, Soong BW, Strupp M, Van Overwalle F, Schmahmann JD. Management of patients with cerebellar Ataxia during the COVID-19 pandemic: current concerns and future implications. Cerebellum. 2020;19(4):562\u20138. https:\/\/doi.org\/10.1007\/s12311-020-01139-1. PMID: 32405955; PMCID: PMC7220536.","journal-title":"Cerebellum"},{"issue":"10","key":"3005_CR19","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1111\/imj.15473","volume":"51","author":"U Ramaswami","year":"2021","unstructured":"Ramaswami U, D\u2019Amore S, Finnegan N, Hughes D, Kazemi M, Lysosomal Disorders Team, Royal Free London NHS Foundation Trust. Impact of SARS-CoV-2 (COVID-19) pandemic on patients with lysosomal storage disorders and restoration of services: experience from a specialist centre. Intern Med J. 2021;51(10):1580\u201393. https:\/\/doi.org\/10.1111\/imj.15473. Epub 2021 Sep 23. PMID: 34487419; PMCID: PMC8652804.","journal-title":"Intern Med J"},{"issue":"7","key":"3005_CR20","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1007\/s10072-021-05252-9","volume":"42","author":"D Pareyson","year":"2021","unstructured":"Pareyson D, Pantaleoni C, Eleopra R, De Filippis G, Moroni I, Freri E, Zibordi F, Bulgheroni S, Pagliano E, Sarti D, Silvani A, Grazzi L, Tiraboschi P, Didato G, Anghileri E, Bersano A, Valentini L, Piacentini S, Muscio C, Leonardi M, Mariotti C, Eoli M, Nuzzo S, Tagliavini F, Confalonieri P, De Giorgi F. Besta-Telehealth Task Force. Neuro-telehealth for fragile patients in a tertiary referral neurological institute during the COVID-19 pandemic in Milan, Lombardy. Neurol Sci. 2021;42(7):2637\u201344. https:\/\/doi.org\/10.1007\/s10072-021-05252-9. Epub 2021 Apr 30. PMID: 33929645; PMCID: PMC8086222.","journal-title":"Neurol Sci"},{"issue":"1","key":"3005_CR21","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13052-021-00975-z","volume":"47","author":"E Mercuri","year":"2021","unstructured":"Mercuri E, Zampino G, Morsella A, Pane M, Onesimo R, Angioletti C, Valentini P, Rendeli C, Ruggiero A, Nanni L, Chiaretti A, Vento G, Korn D, Meneschincheri E, Sergi P, Scambia G, Ricciardi W, Cambieri A, De Belvis AG. Contactless: a new personalised telehealth model in chronic pediatric Diseases and disability during the COVID-19 era. Ital J Pediatr. 2021;47(1):29. https:\/\/doi.org\/10.1186\/s13052-021-00975-z. PMID: 33579344; PMCID: PMC7880513.","journal-title":"Ital J Pediatr"},{"issue":"2","key":"3005_CR22","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1089\/tmj.2020.0569","volume":"28","author":"T Zubarioglu","year":"2022","unstructured":"Zubarioglu T, Hopurcuoglu D, Uygur E, Ahmadzada S, Oge-Enver E, Isat E, Cansever MS, Kiykim E, Aktuglu-Zeybek C. The impact of Telemedicine for Monitoring and Treatment of Phenylketonuria patients on metabolic outcome during coronavirus Disease-19 outbreak. Telemed J E Health. 2022;28(2):258\u201365. Epub 2021 Mar 12. PMID: 33719565.","journal-title":"Telemed J E Health"},{"issue":"Suppl","key":"3005_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4274\/tnd.2021.69851","volume":"27","author":"N \u00c7elik","year":"2021","unstructured":"\u00c7elik N, Kumcu M, Aydemir S, \u00d6zkan S. Patient communication and Consultation Experience with Telemedicine in patients with Movement D\u0131sorders in COVID-19 pandemic: its usability, benefits and problems. Turkish J Neurol. 2021;27(Suppl):9\u201314. https:\/\/doi.org\/10.4274\/tnd.2021.69851.","journal-title":"Turkish J Neurol"},{"issue":"5","key":"3005_CR24","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1002\/mds.28478","volume":"36","author":"M Grobe-Einsler","year":"2021","unstructured":"Grobe-Einsler M, Taheri Amin A, Faber J, Schaprian T, Jacobi H, Schmitz-H\u00fcbsch T, Diallo A, Tezenas du Montcel S, Klockgether T. Development of SARAhome, a New Video-based Tool for the Assessment of Ataxia at Home. Mov Disord. 2021;36(5):1242\u20136. Epub 2021 Jan 12. PMID: 33433030.","journal-title":"Mov Disord"},{"issue":"3","key":"3005_CR25","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s11845-019-02168-4","volume":"189","author":"N Byrne","year":"2020","unstructured":"Byrne N, Turner J, Marron R, Lambert DM, Murphy DN, O\u2019Sullivan G, Mason M, Broderick F, Burke MC, Casey S, Doyle M, Gibney D, Mason F, Molony D, Ormond D, O\u2019 S\u00e9 C, O\u2019Shea C, Treacy EP. The role of primary care in management of rare Diseases in Ireland. Ir J Med Sci. 2020;189(3):771\u20136. https:\/\/doi.org\/10.1007\/s11845-019-02168-4. Epub 2020 Jan 13. PMID: 31933130; PMCID: PMC7363724.","journal-title":"Ir J Med Sci"},{"key":"3005_CR26","doi-asserted-by":"crossref","unstructured":"Ruano L, Melo C, Silva MC, Coutinho P. The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies. Neuroepidemiology. 2014;42(3):174\u2013\u200983. doi: 10.1159\/000358801. Epub 2014 Mar 5. PMID: 24603320.","DOI":"10.1159\/000358801"},{"issue":"1","key":"3005_CR27","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13023-022-02270-4","volume":"17","author":"M Benson","year":"2022","unstructured":"Benson M, Albanese A, Bhatia KP, Cavillon P, Cuffe L, K\u00f6nig K, Reinhard C, Graessner H. Development of a patient journey map for people living with cervical dystonia. Orphanet J Rare Dis. 2022;17(1):130. https:\/\/doi.org\/10.1186\/s13023-022-02270-4. PMID: 35313909; PMCID: PMC8935780.","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"3005_CR28","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1002\/mds.28560","volume":"36","author":"G Defazio","year":"2021","unstructured":"Defazio G, Berardelli A. Is adult-onset Dystonia a Rare Disease? Time for Population-Based studies. Mov Disord. 2021;36(5):1119\u201324. https:\/\/doi.org\/10.1002\/mds.28560. Epub 2021 Mar 16. PMID: 33724530.","journal-title":"Mov Disord"},{"issue":"4","key":"3005_CR29","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1111\/ene.12940","volume":"23","author":"A Valadas","year":"2016","unstructured":"Valadas A, Contarino MF, Albanese A, Bhatia KP, Falup-Pecurariu C, Forsgren L, Friedman A, Giladi N, Hutchinson M, Kostic VS, Krauss JK, Lokkegaard A, Marti MJ, Milanov I, Pirtosek Z, Relja M, Skorvanek M, Stamelou M, Stepens A, Tam\u00e1s G, Taravari A, Tzoulis C, Vandenberghe W, Vidailhet M, Ferreira JJ, Tijssen MA. Management of dystonia in Europe: a survey of the European network for the study of the dystonia syndromes. Eur J Neurol. 2016;23(4):772\u20139. https:\/\/doi.org\/10.1111\/ene.12940. Epub 2016 Jan 29. PMID: 26826067.","journal-title":"Eur J Neurol"},{"key":"3005_CR30","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/1750-1172-8-191","volume":"8","author":"TS Hagedorn","year":"2013","unstructured":"Hagedorn TS, van Berkel P, Hammerschmidt G, Lhot\u00e1kov\u00e1 M, Saludes RP. Requirements for a minimum standard of care for phenylketonuria: the patients\u2019 perspective. Orphanet J Rare Dis. 2013;8:191. https:\/\/doi.org\/10.1186\/1750-1172-8-191. PMID: 24341788; PMCID: PMC3878574.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"3005_CR31","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13023-020-01647-7","volume":"16","author":"AMJ van Wegberg","year":"2021","unstructured":"van Wegberg AMJ, MacDonald A, Abeln D, Hagedorn TS, Lange E, Trefz F, van Vliet D, van Spronsen FJ. Patient\u2019s thoughts and expectations about centres of expertise for PKU. Orphanet J Rare Dis. 2021;16(1):2. https:\/\/doi.org\/10.1186\/s13023-020-01647-7. PMID: 33407655; PMCID: PMC7789756.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"3005_CR32","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13023-017-0685-2","volume":"12","author":"AMJ van Wegberg","year":"2017","unstructured":"van Wegberg AMJ, MacDonald A, Ahring K, B\u00e9langer-Quintana A, Blau N, Bosch AM, Burlina A, Campistol J, Feillet F, Gi\u017cewska M, Huijbregts SC, Kearney S, Leuzzi V, Maillot F, Muntau AC, van Rijn M, Trefz F, Walter JH, van Spronsen FJ. The complete European guidelines on phenylketonuria: diagnosis and treatment. Orphanet J Rare Dis. 2017;12(1):162. https:\/\/doi.org\/10.1186\/s13023-017-0685-2. PMID: 29025426; PMCID: PMC5639803.","journal-title":"Orphanet J Rare Dis"},{"key":"3005_CR33","doi-asserted-by":"publisher","unstructured":"Akar HT, Karaboncuk Y, \u00c7\u0131k\u0131 K, Kahraman AB, Erdal \u0130, Co\u015fkun T, Tokatl\u0131 A, Dursun A, Y\u0131ld\u0131z Y, Sivri HS. COVID-19-related anxiety in phenylketonuria patients. Turk J Pediatr. 2021;63(5):790\u2013800. https:\/\/doi.org\/10.24953\/turkjped.2021.05.007. PMID: 34738361.","DOI":"10.24953\/turkjped.2021.05.007"},{"key":"3005_CR34","doi-asserted-by":"publisher","first-page":"100897","DOI":"10.1016\/j.ymgmr.2022.100897","volume":"32","author":"D Becsei","year":"2022","unstructured":"Becsei D, Kiss E, Szatm\u00e1ri I, Arat\u00f3 A, Reusz G, Szab\u00f3 AJ, B\u00f3kay J, Zsidegh P. A retrospective analysis of metabolic control in children with PKU in the COVID-19 era. Mol Genet Metab Rep. 2022;32:100897. https:\/\/doi.org\/10.1016\/j.ymgmr.2022.100897. PMID: 35845719; PMCID: PMC9284369.","journal-title":"Mol Genet Metab Rep"},{"key":"3005_CR35","doi-asserted-by":"publisher","first-page":"100759","DOI":"10.1016\/j.ymgmr.2021.100759","volume":"27","author":"V Rovelli","year":"2021","unstructured":"Rovelli V, Zuvadelli J, Ercoli V, Montanari C, Paci S, Dionigi AR, Scopari A, Salvatici E, Cefalo G, Banderali G. PKU and COVID19: how the pandemic changed metabolic control. Mol Genet Metab Rep. 2021;27:100759. https:\/\/doi.org\/10.1016\/j.ymgmr.2021.100759. Epub 2021 Apr 23. PMID: 33907667; PMCID: PMC8063433.","journal-title":"Mol Genet Metab Rep"},{"issue":"1","key":"3005_CR36","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/s13023-021-01996-x","volume":"16","author":"M Herle","year":"2021","unstructured":"Herle M, Brunner-Krainz M, Karall D, Goeschl B, M\u00f6slinger D, Zobel J, Plecko B, Scholl-B\u00fcrgi S, Spenger J, Wortmann SB, Huemer M. A retrospective study on Disease management in children and adolescents with phenylketonuria during the Covid-19 pandemic lockdown in Austria. Orphanet J Rare Dis. 2021;16(1):367. https:\/\/doi.org\/10.1186\/s13023-021-01996-x. PMID: 34412683; PMCID: PMC8374407.","journal-title":"Orphanet J Rare Dis"},{"key":"3005_CR37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s12311-021-01351-7","volume":"21","author":"AG Shaikh","year":"2022","unstructured":"Shaikh AG, Manto M, Mitoma H. 2 years into the pandemic: what did we learn about the COVID-19 and Cerebellum? Cerebellum. 2022;21:19\u201322. https:\/\/doi.org\/10.1007\/s12311-021-01351-7.","journal-title":"Cerebellum"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-03005-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-023-03005-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-03005-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T07:06:14Z","timestamp":1708499174000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-023-03005-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,21]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3005"],"URL":"https:\/\/doi.org\/10.1186\/s13023-023-03005-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.07.26.22277799","asserted-by":"object"}]},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,21]]},"assertion":[{"value":"12 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"81"}}